Retraction: Dexamethasone Rescues Neurovascular Unit Integrity from Cell Damage Caused by Systemic Administration of Shiga Toxin 2 and Lipopolysaccharide in Mice Motor Cortex (PLoS ONE 8: 7 (e70020) DOI: 10.1371/journal.pone.0070020);Dexamethasone Rescues Neurovascular Unit Integrity from Cell Damage Caused by Systemic Administration of Shiga Toxin 2 and Lipopolysaccharide in Mice Motor Cortex

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Pinto, Alipio ^a   Jacobsen, Mariana ^a   Geoghegan, Patricia A ^b   Cangelosi, Adriana ^b   Cejudo, María Laura ^a   Tironi Farinati, Carla ^a   Goldstein, Jorge ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Administracion Nacional de Laboratorios E Institutos de Salud Dr Carlos G Malbran   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLIAL FIBRILLARY ACIDIC PROTEIN; LIPOPOLYSACCHARIDE; VASCULOTROPIN; VEROTOXIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL COUNT; CELL DAMAGE; CELL DENSITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; FEMALE; GLYCOCALYX; MICROVASCULATURE; MOTOR CORTEX; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ANIMALIA; ESCHERICHIA COLI; MURINAE; MUS;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANIMALS; BRAIN MAPPING; CASE-CONTROL STUDIES; CELL PHYSIOLOGICAL PHENOMENA; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; GLUCOSE; HUMANS; LONGITUDINAL STUDIES; MALE; MICE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEURAL NETWORKS (COMPUTER); NEUROIMAGING; POSITRON-EMISSION TOMOGRAPHY;

EID: 84880704050     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0295781     Document Type: Erratum

References (73)

1. O'Brien AD, Kaper JB, (1998) Shiga toxin-producing Escherichia coli: yesterday, today, and tomorrow. In: Kaper JB, O'Brien AD, eds. Escherichia coli O157:H7 and Other Shiga Toxin-Producing E. coli Strains. Am Soc Microbiology Washington, DC. pp. pp. 1-11.
2. Proulx F, Seidman EG, Karpman D, (2001) Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome. Pediatr Res 50: 163-171. doi:10.1203/00006450-200108000-00002. PubMed: 11477199.
3. Rivas M, Caletti MG, Chinen I, Refi SM, Roldán CD, et al. (2003) Home-prepared hamburger and sporadic hemolytic uremic syndrome, Argentina. Emerg Infect Dis 9: 1184-1186. doi:10.3201/eid0909.020563. PubMed: 14531383.
4. Exeni RA, (2001) syndrome urémico hemolítico. Arch Latin Nefr Ped 1: 35-56.
5. Eriksson KJ, Boyd SG, Tasker RC, (2001) Acute neurology and neurophysiology of haemolytic-uraemic syndrome. Arch Dis Child 84: 434-435. doi:10.1136/adc.84.5.434. PubMed: 11316694.
6. Oakes RS, Siegler RL, McReynolds MA, Pysher T, Pavia AT, (2006) Predictors of fatality in postdiarrheal hemolytic uremic syndrome. Pediatrics 117: 1656-1662. doi:10.1542/peds.2005-0785. PubMed: 16651320.
7. Grisaru S, Midgley JP, Hamiwka LA, Wade AW, Samuel SM, (2011) Diarrhea-associated hemolytic uremic syndrome in southern Alberta: A long-term single-centre experience. Paediatr Child Health 16: 337-340. PubMed: 22654544.
8. Weissenborn K, Donnerstag F, Kielstein JT, Heeren M, Worthmann H, et al. (2012) Hemolytic-uremic syndrome in adults neurologic manifestations of e coli infection-induced hemolytic-uremic syndrome in adults. Neurology 79: 1466-1473. doi:10.1212/WNL.0b013e31826d5f26. PubMed: 22993286.
9. Voyer LE, (1998) Síndrome urémico hemolítico: aspectos epidemiológicos de clínicas y patogenia. In: Seijo A, Larghi O, Espinosa M, Rivas M, Sabatini M, eds. Temas de zoonosis y enfermedades emergentes. Buenos Aires: Asociación Argentina de Zoonosis. pp. pp. 46-49.
10. Rivas M, Padola NL, Luchessi PM, Masana M, (2010) diarrheogenic Escherichia coli in Argentina. In: Torres AG, eds. Pathogenic Escherichia coli in Latin America. Oak Park IL, USA: Bentham Science Publishers Ltd. pp. pp. 142-161.
11. Upadhyaya K, Barwick K, Fishaut M, Kashgarian M, Siegel NJ, (1980) The importance of nonrenal involvement in hemolytic uremic syndrome. Pediatrics 65: 115-120. PubMed: 7355005.
12. Shetb KJ, Swick HM, Haworth N, (1986) Neurologic involvement in hemolytic uremic syndrome. Ann Neurol 19: 90-99. doi:10.1002/ana.410190120. PubMed: 3947042.
13. Hahn JS, Havens PL, Higgins JJ, O'Rourke PP, Estroff JA, et al. (1989) Neurologic complications of hemolytic uremic syndrome. J Child Neurol 4: 108-113. doi:10.1177/088307388900400206. PubMed: 2715605.
14. Bale JF Jr., Brasher C, Siegler RL, (1980) CNS manifestations of the hemolytic-uremic syndrome. Relationship to metabolic alterations and prognosis. Am J Dis Child 134: 869-872. PubMed: 7416114.
15. Brascher C, Siegler RL, (1981) The hemolytic-uremic syndrome. West J Med 134: 193-197. PubMed: 7269554.
16. Karmali MA, Petric M, Lim C, Fleming PC, Arbus GS, et al. (1985) The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 151: 775-782. doi:10.1093/infdis/151.5.775. PubMed: 3886804.
17. Rooney JC, Anderson RM, Hopkins IJ, (1971) Clinical and pathologic aspects of central nervous system involvement in the haemolytic uraemic syndrome. Proc Aust Assoc Neurol 8: 67-75.
18. Sheth KJ, Swick HM, Haworth N, (1996) Neurological involvement in hemolytic-uremic syndrome. Ann Neurol 19: 90-93.
19. Siegler RL, Pavia AT, Christofferson RD, Milligan MK, (1994) A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah. Pediatrics 94: 35-40. PubMed: 8008534.
20. Taylor CM, White RH, Winterborn MH, Rowe B, (1986) Haemolytic-uraemic syndrome: clinical experience of an outbreak in the West Midlands. Br Med J (Clin Res Ed) 292: 1513-1516. doi:10.1136/bmj.292.6534.1513.
21. Upadhyaya K, Barwick K, Fishaut M, Kashgarian M, Siegel NJ, (1980) The importance of nonrenal involvement in hemolytic-uremic syndrome. Pediatrics 65: 115-120. PubMed: 7355005.
22. Verweyen HM, Karch H, Allerberger F, Zimmerhackl LB, (1999) Enterohemorrhagic Escherichia coli (EHEC) in pediatric hemolytic-uremic syndrome: a prospective study in Germany and Austria. Infection 27: 341-347. doi:10.1007/s150100050040. PubMed: 10624594.
23. Cimolai N, Morrison BJ, Carter JE, (1992) Risk factors for the central nervous system manifestations of gastroenteritis-associated hemolytic-uremic syndrome. Pediatrics 90: 616-621. PubMed: 1408519.
24. Gianantoni CA, Vitacco M, Mendilaharzu F, Gallo GE, Sojo ET, (1973) The hemolytic-uremic syndrome. Nephron 11: 174-192. doi:10.1159/000180229. PubMed: 4542964.
25. Hamano S, Nakanishi Y, Nara T, Seki T, Ohtani T, et al. (1993) Neurological manifestations of hemorrhagic colitis in the outbreak of Escherichia coli O157:H7 infection in Japan. Acta Paediatr 82: 454-458. doi:10.1111/j.1651-2227.1993.tb12721.x. PubMed: 8518521.
26. Tapper D, Tarr P, Avner E, Brandt J, Waldhausen J, (1995) Lessons learned in the management of hemolytic uremic syndrome in children. J Pediatr Surg 30: 158-163. doi:10.1016/0022-3468(95)90554-5. PubMed: 7738732.
27. Obata F, Tohyama K, Bonev AD, Kolling GL, Keepers TR, et al. (2008) Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons. J Infect Dis 198: 1398-1406. doi:10.1086/591911. PubMed: 18754742.
28. Tironi-Farinati C, Geoghegan PA, Cangelosi A, Pinto A, Loidl CF, et al. (2013) A Translational Murine Model of Sub-Lethal Intoxication with Shiga Toxin 2 Reveals Novel Ultrastructural Findings in the Brain Striatum. PLOS ONE 8(1):: e55812. doi:10.1371/journal.pone.0055812. PubMed: 23383285.
29. Zhang H, Peterson JW, Niesel DW, Klimpel GR, (1997) Bacterial lipoprotein and lipopolysaccharide act synergistically to induce lethal shock and proinflammatory cytokine production. J Immunol 159: 4868-4878. PubMed: 9366412.
30. Mazzetti S, Frigerio S, Gelati M, Salmaggi A, Vitellaro-Zuccarello L, (2004) Lycopersicon esculentum lectin: an effective and versatile endothelial marker of normal and tumoral blood vessels in the central nervous system. Eur J Histochem 48: 423-428. PubMed: 15718209.
31. Robertson CL, Puskar A, Hoffman GE, Murphy AZ, Saraswati M, et al. (2006) Physiologic progesterone reduces mitochondrial dysfunction and hippocampal cell loss after traumatic brain injury in female rats. Exp Neurol 197: 235-243. doi:10.1016/j.expneurol.2005.09.014. PubMed: 16259981.
32. Little AR, O'Callaghan JP, (2001) Astrogliosis in the adult and developing CNS: is there a role for proinflammatory cytokines? Neurotoxicology 22: 607-618. doi:10.1016/S0161-813X(01)00032-8. PubMed: 11770882.
33. Benderro GF, Sun X, Kuang Y, LaManna JC, (2012) Decreased VEGF expression and microvascular density, but increased HIF-1 and 2a accumulation and EPO expression in chronic moderate hyperoxia in the mouse brain. Brain Res 1471: 46-55. doi:10.1016/j.brainres.2012.06.055. PubMed: 22820296.
34. Obata F, (2010) Influence of Escherichia coli shiga toxin on the mammalian central nervous system. Adv Appl Microbiol 71: 1-19. doi:10.1016/S0065-2164(10)71001-7. PubMed: 20378049.
35. Goldstein J, Loidl CF, Creydt VP, Boccoli J, Ibarra C, (2007) Intracerebroventricular administration of Shiga toxin type 2 induces striatal neuronal death and glial alterations: an ultrastructural study. Brain Res 1161: 106-115. doi:10.1016/j.brainres.2007.05.067. PubMed: 17610852.
36. Candiano G, Bruschi M, Musante L, Santucci L, Ghiggeri GM, et al. (2004) Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 25: 1327-1333. doi:10.1002/elps.200305844. PubMed: 15174055.
37. Tironi-Farinati C, Loidl CF, Boccoli J, Parma Y, Fernandez-Miyakawa ME, et al. (2010) Intracerebroventricular Shiga toxin 2 increases the expression of its receptor globotriaosylceramide and causes dendritic abnormalities. J Neuroimmunol 222: 48-61. doi:10.1016/j.jneuroim.2010.03.001. PubMed: 20347160.
38. Paxinos G, Franklin KBJ, (2001) The mouse brain in stereotaxic coordinates. San Diego, CA: Academic Press.
39. Fujii J, Kinoshita Y, Kita T, Higure A, Takeda T, et al. (1996) Magnetic resonance imaging and histopathological study of brain lesions in rabbits given intravenous verotoxin 2. Infect Immun 64: 5053-5060. PubMed: 8945546.
40. Mizuguchi M, Sugatani J, Maeda T, Momoi T, Arima K, et al. (2001) Cerebrovascular damage in young rabbits after intravenous administration of Shiga toxin 2. Acta Neuropathol 102: 306-312. PubMed: 11603804.
41. Kita E, Yunou Y, Kurioka T, Harada H, Yoshikawa S, et al. (2000) Pathogenic mechanism of mouse brain damage caused by oral infection with Shiga toxin-producing Escherichia coli O157:H7. Infect Immun 68: 1207-1214. doi:10.1128/IAI.68.3.1207-1214.2000. PubMed: 10678928.
42. Louise CB, Obrig TG, (1992) Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. Infect Immun 60: 1536-1543. PubMed: 1548077.
43. Bitzan M, Moebius E, Ludwig K, Muller-Wiefel DE, Heesemann J, et al. (1991) High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome. J Pediatr 119: 380-385. doi:10.1016/S0022-3476(05)82049-9. PubMed: 1880650.
44. Koster F, Levin J, Walker L, Tung K, Gilman R, et al. (1978) Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes. N Engl J Med 298: 927-933. doi:10.1056/NEJM197804272981702. PubMed: 642973.
45. Keepers TR, Psotka MA, Gross LK, Obrig TG, (2006) A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease. J Am Soc Nephrol 17: 3404-3414. doi:10.1681/ASN.2006050419. PubMed: 17082244.
46. Nieuwdorp M, Meuwese MC, Vink H, Hoekstra JBL, Kastelen JJP, et al. (2005) The endothelial glycocalyx: a potential barrier between health and vascular disease. Curr Opin Lipidol 16: 507-511. doi:10.1097/01.mol.0000181325.08926.9c. PubMed: 16148534.
47. Henry CB, Duling BR, (1999) Permeation of the luminal capillary glycocalyx is determined by hyaluronam. Am J Physiol 277: H508-H514. PubMed: 10444475.
48. Vink H, Duling BR, (2000) Capillary endothelial surface layer selectively reduces plasma solute distribution volume. Am J Physiol Heart Circ Physiol 278: H285-H289. PubMed: 10644610.
49. Ueno M, (2009) Mechanisms of the Penetration of Blood-Borne Substances into the Brain. Curr Neuropharmacol 7: 142-149. doi:10.2174/157015909788848901. PubMed: 19949573.
50. Psotka MA, Obata F, Kolling GL, Gross LK, Saleem MA, et al. (2009) Shiga toxin 2 targets the murine renal collecting duct epithelium. Infect Immun 77: 959-969. doi:10.1128/IAI.00679-08. PubMed: 19124603.
51. Rosenstein JM, Mani N, Khaibullina A, Krum JM, (2003) Neurotrophic effects of vascular endothelial growth factor on organotypic cortical explants and primary cortical neurons. J Neurosci 23: 11036-11044. PubMed: 14657160.
52. Silverman WF, Krum JM, Mani N, Rosenstein JM, (1999) Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explants cultures. Neuroscience 90: 1529-1541. doi:10.1016/S0306-4522(98)00540-5. PubMed: 10338318.
53. Khaibulina AA, Rosenstein JM, Krum JM, (2004) Vascular endothelial growth factor promotes neurite maturation in primary CNS neuronal cultures. Brain Res Dev Brain Res 148: 59-68. doi:10.1016/j.devbrainres.2003.09.022. PubMed: 14757519.
54. Sugatani J, Igarashi T, Munakata M, Komiyama Y, Takahashi H, et al. (2000) Activation of coagulation in C57BL/6 mice given verotoxin 2 (VT2) and the effect of co-administration of LPS with VT2. Thromb Res 100: 61-72. doi:10.1016/S0049-3848(00)00305-4. PubMed: 11053618.
55. Boccoli J, Loidl CF, Lopez-Costa JJ, Creydt VP, Ibarra C, et al. (2008) Intracerebroventricular administration of Shiga toxin type 2 altered the expression levels of neuronal nitric oxide synthase and glial fibrillary acidic protein in rat brains. Brain Res 1230: 320-333. doi:10.1016/j.brainres.2008.07.052. PubMed: 18675791.
56. Pekny M, Wilhelmsson U, Bogestål YR, Pekna M, (2007) The role of astrocytes and complement system in neural plasticity. Int Rev Neurobiol 82: 95-111. doi:10.1016/S0074-7742(07)82005-8. PubMed: 17678957.
57. Jacob A, Hensley LK, Safratowich BD, Quigg RJ, Alexander JJ, (2007) The role of the complement cascade in endotoxin-induced septic encephalopathy. Lab Invest 87: 1186-1194. doi:10.1038/labinvest.3700686. PubMed: 17922019.
58. Sofroniew MV, Vinters HV, (2010) Astrocytes: biology and pathology. Acta Neuropathol 119: 7-35. doi:10.1007/s00401-009-0619-8. PubMed: 20012068.
59. Murray CL, Skelly DT, Cunningham C, (2001) Exacerbation of CNS inflammation and neurodegeneration by systemic LPS treatment is independent of circulating Il-1β and IL-6. J Neuroinflammation 8: 50.
60. Xing B, Bachstetter AD, Van-Eldik LJ, (2011) Microglial p38α MAPK is critical for LPS-induced neuron degeneration, through a mechanism involving TNFα. Mol Neurodegener 6: 84. doi:10.1186/1750-1326-6-84. PubMed: 22185458.
61. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A, (2011) Physiology of microglia. Physiol Rev 91: 461-553. doi:10.1152/physrev.00011.2010. PubMed: 21527731.
62. Winter KRK, Stoffregen WC, Dean-Nystrom EA, (2004) Shiga toxin binding to isolated porcine tissues and peripheral blood leukocytes. Infect Immun 72: 6680-6684. doi:10.1128/IAI.72.11.6680-6684.2004. PubMed: 15501802.
63. Saxena SK, O'Brien AD, Ackerman EJ, (1989) Shiga toxin, Shiga-like toxin II variant, and ricin are all single-site when microinjected into Xenopus oocytes. J Biol Chem 264: 596-601. PubMed: 2642481.
64. Lindauer ML, Wong J, Iwakura Y, Magun BE, (2009) Pulmonary Inflammation Triggered by Ricin Toxin Requires Macrophages and IL-1 Signaling. J Immunol 183: 1419-1426. doi:10.4049/jimmunol.0901119. PubMed: 19561099.
65. Iordanov MS, Pribnow D, Magun JL, Dinh TH, Pearson JA, et al. (1997) Ribotoxic stress response: activation of the stress-activated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the alpha-sarcin/ricin loop in the 28S rRNA. Mol Cell Biol 17: 3373-3381. PubMed: 9154836.
66. Kimmitt PT, Harwood CR, Barer MR, (2000) Toxin gene expression by Shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response. Emerg Infect Dis 6: 458-465. doi:10.3201/eid0605.000503. PubMed: 10998375.
67. Zhang X, McDaniel AD, Wolf LE, Keusch GT, Waldor MK, et al. (2000) Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J Infect Dis 181: 664-670. doi:10.1086/315239. PubMed: 10669353.
68. Katz J, Lurie A, Kaplan BS, Krawitz S, Metz J, (1971) Coagulation findings in the hemolytic-uremic syndrome of infancy: similarity to hyperacute renal allograft rejection J Pediatr 78: 426-434.
69. Bell BP, Griffin PM, Lozano P, Christie DL, Kobayashi JM, et al. (1997) Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics 100: E12. doi:10.1542/peds.100.1.e12. PubMed: 9200386.
70. Dundas S, Todd WT, Stewart AI, Murdoch PS, Chaudhuri AK, et al. (2001). Cent Scotland Escherichia Coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients Clin Infect Dis 33: 923-931.
71. Forster C, Waschke J, Burek M, Leers J, Drenckhahn D, (2006) Glucocorticoid effects on mouse microvascular endothelial barrier permeability are brain specific. J Physiol 573: 413-425. doi:10.1113/jphysiol.2006.106385. PubMed: 16543270.
72. Liu CC, Chien CH, Lin MT, (2000) Glucocorticoids reduce interleukin-1β concentration and result in neuroprotective effects in rat heatstroke. J Physiol 527: 333-343. doi:10.1111/j.1469-7793.2000.t01-1-00333.x. PubMed: 10970434.
73. Siegler RL, Pysher TJ, Lou R, Tesh VL, Taylor FB Jr, (2001) Response to Shiga toxin-1, with and without lipopolysaccharide, in primate model of hemolytic uremic syndrome. Am J Nephrol 21: 420-425. doi:10.1159/000046288. PubMed: 11684808.